Maximize Your Impact At LSX Investival Showcase UK 2025
LSX Investival Showcase UK 2025, taking place on November 17 at Old Billingsgate in London, brings together the most influential players in the global life sciences and healthcare investment landscape. This event is known for forging connections between high-growth biotech, medtech, and healthtech companies and the investment firms that shape the future of healthcare innovation.
The attendees include CEOs from early to late-stage startups, institutional investors, venture funds, family offices, and pharma executives with decision-making authority over partnerships, funding, and commercialization strategies. These are the professionals deciding where resources go for scientific breakthroughs, clinical advancements, and next-generation diagnostics.
Using the enriched attendee list gives your team visibility into these high-value stakeholders ahead of the event. Business development and partnership leads can strategically prioritize outreach to secure meetings with capital allocators, align messaging to current portfolio goals, and prepare for on-site discussions that drive outcomes beyond introductions.
How Sales, Marketing and Revops Teams Can Use This Attendee List
For commercial teams selling into biotech, pharma, or digital health, Vendelux’s enriched attendee list is a foundational asset. You can segment conference attendees by company size, investment activity, or stage of development to tailor interactions across commercial and scientific paths.
Sales and marketing leaders can prioritize outreach to managing partners, R&D heads, corporate development leads, and innovation scouts who own budgetary and collaboration decisions. With verified contacts and detailed profiles, your outreach can center on capital alignment, recent funding activity, and platform compatibility—helping you get more meetings with the people who influence multi-year purchasing and investment strategies.
On-site conversations often begin with pre-arranged meetings, and the attendee data helps craft purposeful sessions. After the event, follow-up becomes more effective when aligned with attendee-specific priorities and the discussions that took place at LSX.
Timing Is Everything
LSX Investival Showcase UK 2025 will be held on November 17, 2025. With just over six months remaining, early engagement is critical. Investment firms and fast-scaling life sciences companies have packed calendars heading into year-end evaluations and planning cycles.
Using Vendelux, your team can align its strategies with attendee priorities and start outreach well before calendars fill up. This ensures that relationship-building conversations begin before the event and can continue in-person with a stronger foundation.
What’s Included In The LSX Investival Showcase UK 2025 Attendee List?
Vendelux provides visibility into the key stakeholders expected to attend LSX Investival Showcase UK 2025 through organizer data and predictive intelligence. Users can upload target account lists to identify in-network matches.
The enriched attendee list includes first and last names, job titles, company names, company websites, locations (city, country), LinkedIn profiles, business email addresses, and phone numbers when available.
Where Is LSX Investival Showcase UK 2025?
The event will take place at Old Billingsgate in London, England, United Kingdom.
When Is LSX Investival Showcase UK 2025?
LSX Investival Showcase UK 2025 is scheduled for November 17, 2025.
What Type Of Event Is LSX Investival Showcase UK 2025?
LSX Investival Showcase UK 2025 is a premier investor and partnering conference focused on the life sciences and healthcare innovation sectors. The event features company showcases, keynote panels, and one-to-one partnering sessions that facilitate connections between biotech leaders and capital sources.
How Many People Attend LSX Investival Showcase UK 2025?
The event is expected to draw over 500 attendees from across global biotech hubs, including executives from investment firms, pharmaceutical companies, and high-growth startups at various development stages. Most attendees hold senior leadership roles, with a strong concentration of CEOs, venture partners, and heads of corporate strategy.
